Krystal Biotech Inc.

In News

Is Krystal Biotech (KRYS) Still Attractively Priced After Its Strong Multi Year Share Price Run - Yahoo Finance

Yahoo Finance - Jan 10, 2026

Krystal Biotech, Inc. Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study - TradingView — Track All Markets

TradingView — Track All Markets - Jan 08, 2026

Krystal Biotech, Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 - Quiver Quantitative

Quiver Quantitative - Jan 05, 2026

Citigroup Upgrades Krystal Biotech (KRYS) - Nasdaq

Nasdaq - Jan 07, 2026

Citigroup Raises Price Target for Krystal Biotech (KRYS) to $320 - GuruFocus

GuruFocus - Jan 09, 2026

Early test data on an inhaled cystic fibrosis treatment to be revealed - Stock Titan

Stock Titan - Jan 07, 2026

Assessing Krystal Biotech (KRYS) Valuation As Investors Await CORAL-1 KB407 Interim Cystic Fibrosis Data - Sahm

Sahm - Jan 09, 2026

Assessing Krystal Biotech (KRYS) Valuation After Positive KB407 Cystic Fibrosis Trial Update - Yahoo Finance

Yahoo Finance - Jan 10, 2026

Jefferies raises Krystal Biotech stock price target to $310 on CF data - Investing.com

Investing.com - Jan 09, 2026

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis - MarketScreener

MarketScreener - Jan 07, 2026

Krystal Biotech Announces Investor Conference Call for Interim Clinical Update on KB407 in Cystic Fibrosis Study - Quiver Quantitative

Quiver Quantitative - Jan 07, 2026

Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis - Stock Titan

Stock Titan - Jan 08, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment